Primary Site >> Colorectal Cancer

Gene >> GALNT14

Journal: Clin Cancer Res. 2010 Mar 1;16(5):1587-96.
Title: Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
Author: Stern, Howard M|Padilla, Mary|Wagner, Klaus|Amler, Lukas|Ashkenazi, Avi
PMID: 20179215
Journal: Medicine (Baltimore). 2016 Apr;95(17):e3487.
Title: GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Author: Lin, Wey-Ran|Chiang, Jy-Ming|Liang, Kung-Hao|Lim, Siew-Na|Lai, Ming-Wei|Tsou, Yung-Kuan|Hsieh, Tzu-Yun|Hsu, Chih-Kai|Yeh, Chau-Ting
PMID: 27124048
Journal: J Cancer. 2018 Sep 8;9(19):3540-3547.
Title: Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype.
Author: Chen, Tsung-Hsing|Lin, Wey-Ran|Lee, Chieh|Chiu, Cheng-Tang|Hsu, Jun-Te|Yeh, Ta-Sen|Lin, Kwang-Huei|Le, Puo-Hsien|Yeh, Chau-Ting
PMID: 30310511